APA (7th ed.) Citation

Cao, Y., Huang, S., He, Y., Zhang, Y., Chen, S., Huang, M., . . . Fang, M. (2025). Discovery of 4-(2-(methylamino)thiazol-5-yl)pyrimidin-2-amine derivatives as novel cyclin-dependent kinase 12 (CDK12) inhibitors for the treatment of esophageal squamous cell carcinoma. Bioorganic chemistry.

Chicago Style (17th ed.) Citation

Cao, Yin, et al. Discovery of 4-(2-(methylamino)thiazol-5-yl)pyrimidin-2-amine Derivatives as Novel Cyclin-dependent Kinase 12 (CDK12) Inhibitors for the Treatment of Esophageal Squamous Cell Carcinoma. Bioorganic chemistry, 2025.

MLA (9th ed.) Citation

Cao, Yin, et al. Discovery of 4-(2-(methylamino)thiazol-5-yl)pyrimidin-2-amine Derivatives as Novel Cyclin-dependent Kinase 12 (CDK12) Inhibitors for the Treatment of Esophageal Squamous Cell Carcinoma. Bioorganic chemistry, 2025.